CIK 2056095
Banque Transatlantique SA
Institutional 13F holdings & portfolio
Holdings
518
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
2
Holdings
13F filings as of Dec 31, 2025 · Showing 201–250 of 518
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| ULTA | ULTA BEAUTY INC | 718 | $100K–$500K | SH |
| ULTA | ULTA BEAUTY INC | 718 | $100K–$500K | SH |
| EEM | ISHARES TR | 8K | $100K–$500K | SH |
| EEM | ISHARES TR | 8K | $100K–$500K | SH |
| DG | DOLLAR GEN CORP NEW | 3K | $100K–$500K | SH |
| DG | DOLLAR GEN CORP NEW | 3K | $100K–$500K | SH |
| NEM | NEWMONT CORP | 4K | $100K–$500K | SH |
| NEM | NEWMONT CORP | 4K | $100K–$500K | SH |
| MMM | 3M CO | 3K | $100K–$500K | SH |
| MMM | 3M CO | 3K | $100K–$500K | SH |
| SHW | SHERWIN WILLIAMS CO | 1K | $100K–$500K | SH |
| SHW | SHERWIN WILLIAMS CO | 1K | $100K–$500K | SH |
| EL | LAUDER ESTEE COS INC | 3K | $100K–$500K | SH |
| EL | LAUDER ESTEE COS INC | 3K | $100K–$500K | SH |
| EQIX | EQUINIX INC | 432 | $100K–$500K | SH |
| EQIX | EQUINIX INC | 432 | $100K–$500K | SH |
| QQQ | INVESCO QQQ TR | 470 | $100K–$500K | SH |
| QQQ | INVESCO QQQ TR | 470 | $100K–$500K | SH |
| CRS | CARPENTER TECHNOLOGY CORP | 903 | $100K–$500K | SH |
| CRS | CARPENTER TECHNOLOGY CORP | 903 | $100K–$500K | SH |
| IWM | ISHARES TR | 1K | $100K–$500K | SH |
| IWM | ISHARES TR | 1K | $100K–$500K | SH |
| SLB | SLB LIMITED | 6K | $100K–$500K | SH |
| SLB | SLB LIMITED | 6K | $100K–$500K | SH |
| MS | MORGAN STANLEY | 1K | $100K–$500K | SH |
| MS | MORGAN STANLEY | 1K | $100K–$500K | SH |
| VRTX | VERTEX PHARMACEUTICALS INC | 539 | $100K–$500K | SH |
| VRTX | VERTEX PHARMACEUTICALS INC | 539 | $100K–$500K | SH |
| CVX | CHEVRON CORP NEW | 2K | $100K–$500K | SH |
| CVX | CHEVRON CORP NEW | 2K | $100K–$500K | SH |
| ASML | ASML HOLDING N V | 212 | $100K–$500K | SH |
| ASML | ASML HOLDING N V | 212 | $100K–$500K | SH |
| VOO | VANGUARD INDEX FDS | 365 | $100K–$500K | SH |
| VOO | VANGUARD INDEX FDS | 365 | $100K–$500K | SH |
| UBS | UBS GROUP AG | 5K | $100K–$500K | SH |
| UBS | UBS GROUP AG | 5K | $100K–$500K | SH |
| SPGI | S&P GLOBAL INC | 415 | $100K–$500K | SH |
| SPGI | S&P GLOBAL INC | 415 | $100K–$500K | SH |
| RSP | INVESCO EXCHANGE TRADED FD T | 1K | $100K–$500K | SH |
| RSP | INVESCO EXCHANGE TRADED FD T | 1K | $100K–$500K | SH |
| PLD | PROLOGIS INC. | 2K | $100K–$500K | SH |
| PLD | PROLOGIS INC. | 2K | $100K–$500K | SH |
| REGN | REGENERON PHARMACEUTICALS | 254 | $100K–$500K | SH |
| REGN | REGENERON PHARMACEUTICALS | 254 | $100K–$500K | SH |
| WAB | WABTEC | 898 | $100K–$500K | SH |
| WAB | WABTEC | 898 | $100K–$500K | SH |
| VEEV | VEEVA SYS INC | 860 | $100K–$500K | SH |
| VEEV | VEEVA SYS INC | 860 | $100K–$500K | SH |
| ABBV | ABBVIE INC | 808 | $100K–$500K | SH |
| ABBV | ABBVIE INC | 808 | $100K–$500K | SH |